back
SEDI Insider filing browser
| Date | Issuer | Insider | Transaction | Amount | New Balance ⓘ
The balance of securities held by registered holder at the time of the transaction. Insiders may direct multiple registered holders and hold multiple security types.
|
|
|---|---|---|---|---|---|---|
| Filed 2025-09-09 17:58 Tx date 2025-09-05 |
$GENX
Genix Pharmaceuticals Corporation |
Mahmoud, Aziz
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Warrants
53 - Grant of warrants
|
+1,000,000 vol |
1,000,000 | |
| Filed 2025-09-09 17:57 Tx date 2021-05-19 |
$GENX
Genix Pharmaceuticals Corporation |
Mahmoud, Aziz
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Warrants
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2025-09-09 17:57 Tx date 2025-09-05 |
$GENX
Genix Pharmaceuticals Corporation |
Mahmoud, Aziz
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
|
$50,000
+1,000,000 vol $0.05 each |
7,419,671 | |
| Filed 2025-09-09 17:55 Tx date 2025-09-05 |
$GENX
Genix Pharmaceuticals Corporation |
Pirooz, Sina
4 - Director of Issuer
Direct Ownership
|
Warrants
53 - Grant of warrants
|
+1,000,000 vol |
1,000,000 | |
| Filed 2025-09-09 17:55 Tx date 2018-08-27 |
$GENX
Genix Pharmaceuticals Corporation |
Pirooz, Sina
4 - Director of Issuer
Direct Ownership
|
Warrants
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2025-09-09 17:54 Tx date 2025-09-05 |
$GENX
Genix Pharmaceuticals Corporation |
Pirooz, Sina
4 - Director of Issuer
Direct Ownership
|
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
|
$50,000
+1,000,000 vol $0.05 each |
1,891,300 | |
| Filed 2024-04-16 13:08 Tx date 2024-04-15 |
$GENX
Genix Pharmaceuticals Corporation |
Pirooz, Sina
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-9,360
-144,000 vol $0.065 each |
891,300 | |
| Filed 2024-04-16 13:07 Tx date 2024-04-15 |
$GENX
Genix Pharmaceuticals Corporation |
Pirooz, Sina
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-110.50
-1,700 vol $0.065 each |
1,035,300 | |
| Filed 2024-03-27 12:49 Tx date 2024-03-22 |
$GENX
Genix Pharmaceuticals Corporation |
Pirooz, Sina
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-30,225
-403,000 vol $0.075 each |
1,037,000 | |
| Filed 2023-12-28 14:18 Tx date 2023-12-27 |
$GENX
Genix Pharmaceuticals Corporation |
Chow, Paul
3 - 10% Security Holder of Issuer, 4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$740.00
+37,000 vol $0.02 each |
10,501,110 | |
| Filed 2023-12-20 12:31 Tx date 2023-12-18 |
$GENX
Genix Pharmaceuticals Corporation |
Chow, Paul
3 - 10% Security Holder of Issuer, 4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$5,250
+150,000 vol $0.035 each |
10,464,110 | |
| Filed 2023-07-02 16:49 Tx date 2023-06-28 |
$GENX
Genix Pharmaceuticals Corporation |
Chow, Paul
3 - 10% Security Holder of Issuer, 4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$605.00
+11,000 vol $0.055 each |
10,244,110 | |
| Filed 2023-07-02 16:47 Tx date 2023-06-28 |
$GENX
Genix Pharmaceuticals Corporation |
Chow, Paul
3 - 10% Security Holder of Issuer, 4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$3,780
+70,000 vol $0.054 each |
10,314,110 | |
| Filed 2023-06-29 19:05 Tx date 2023-06-28 |
$GENX
Genix Pharmaceuticals Corporation |
Chow, Paul
3 - 10% Security Holder of Issuer, 4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$3,355
+61,000 vol $0.055 each |
||
| Filed 2023-06-29 19:04 Tx date 2023-06-28 |
$GENX
Genix Pharmaceuticals Corporation |
Chow, Paul
3 - 10% Security Holder of Issuer, 4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$1,000
+20,000 vol $0.05 each |
||
| Filed 2023-06-29 19:05 Tx date 2023-06-28 |
$GENX
Genix Pharmaceuticals Corporation |
Chow, Paul
3 - 10% Security Holder of Issuer, 4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$3,355
+61,000 vol $0.055 each |
10,314,110 | |
| Filed 2023-06-29 19:04 Tx date 2023-06-28 |
$GENX
Genix Pharmaceuticals Corporation |
Chow, Paul
3 - 10% Security Holder of Issuer, 4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$1,000
+20,000 vol $0.05 each |
10,253,110 | |
| Filed 2023-06-21 21:29 Tx date 2021-03-22 |
$GENX
Genix Pharmaceuticals Corporation |
Pirooz, Sina
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$6,000
+50,000 vol $0.12 each |
350,000 | |
| Filed 2023-06-21 21:29 Tx date 2020-08-10 |
$GENX
Genix Pharmaceuticals Corporation |
Pirooz, Sina
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$36,000
+300,000 vol $0.12 each |
300,000 | |
| Filed 2023-06-21 21:27 Tx date 2020-08-06 |
$GENX
Genix Pharmaceuticals Corporation |
Bottomley, Kevin
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$36,000
+300,000 vol $0.12 each |
300,000 |